Fluorescence Lifetime Imaging Ophthalmoscopy kit
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- Not on record
- Points of contact
-
- CDRH Acquisition Liaison cdhracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring a Fluorescence Lifetime Imaging Ophthalmoscopy kit—a specialized hardware and software system for laser-scanning ophthalmoscopes to capture optical fluorescence signals from the eye. The equipment supports regulatory science research on fluorescence-based biomarkers in age-related macular degeneration, glaucoma, and aging; solicitation release is estimated for May 1, 2027, with award expected July 1, 2027.
The estimated award value ranges from $25,000 to $250,000. Inquiries should be directed to the FDA's Center for Drug and Radiological Health Acquisitions mailbox at cdhracquisitions@fda.hhs.gov.
Forecast text
BPID: 895 - Fluorescence Lifetime Imaging Ophthalmoscopy kit is a specialized set of hardware/software components which enable laser-scanning ophthalmoscope to interrogate optical fluorescence signals from the eye. This imaging modality provides the basis for researching the fluorescence-based biomarkers in eye diseases and aging. This equipment will allow for data acquisition under ophthalmic program regulatory science research for biomarkers of AMD, glaucoma and aging.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast